Tropicamide Completed Phase 3 Trials for Eye Diseases Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00120432Single Dose of 1% Tropicamide and 10% Phenylephrine for Pupillary Dilation